European Archives of Oto-Rhino-Laryngology

, Volume 265, Issue 10, pp 1245–1255

The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy

  • Fadime Can Akman
  • Nihal Dag
  • Ozlem Uruk Ataman
  • Cenk Ecevit
  • Ahmet Omer Ikiz
  • Isin Arslan
  • Sulen Sarıoglu
  • Emel Ada
  • Munir Kinay
  • Dokuz Eylül Head and Neck Tumour Group (DEHNTG)
Head and Neck


For laryngeal cancer, surgical excision of the primary tumor should be undertaken with the aim of achieving tumor-free margins. Adequate pathological assessment of the specimen and the competency of the treatment center play a crucial role in achieving cure. The present study aimed to analyze the significance of place of surgery on the outcome of patients with laryngeal cancer who underwent surgical operation in other centers and were subsequently referred to Doküz Eylul University Head and Neck Tumour Group (DEHNTG) for postoperative irradiation. Patients were divided into three groups according to their place of surgery. The first group (Group I) consisted of patients who had their surgical operation at DEUH. Patients in the second group (Group II) were referred from centers with oncological surgical experience. The third group (Group III) consisted of patients referred from hospitals with no surgical teams experienced in head and neck cancer treatment. The clinical and pathological features of patients in these three groups were analyzed to assess the impact of place of surgery on clinical outcome as well as the prognostic factors for survival. The study population consisted of 253 patients who were treated between 1991 and 2006 with locally advanced laryngeal cancer according to the protocol of DEHNTG. The median follow-up was 48 (3–181) months. The 5 years overall, loco-regional disease-free and distant disease-free survivals were 66, 88 and 91%, respectively. When patients’ clinical and histopathological features were analyzed for the impact of place of surgery, surgical margin positivity rates were found to be higher in Group III (P = 0.032), although the other two groups had more advanced clinical and pathological N stage disease (P = 0.012, P = 0.001). In multivariate analysis, older age (P < 0.0001), presence of perinodal invasion (P = 0.012), time interval between surgery and radiotherapy longer than 6 weeks (P = 0.003) and tumor grade (P = 0.049) were the most significant factors. For loco-regional failure-free survival, advanced clinical stage (P = 0.002), place of surgery (P = 0.031) and presence of clinical subglottic invasion (P = 0.029) were shown to be important prognostic factors. For distant metastasis-free survival, only pathological (+) lymph node status (P = 0.046) was a significant factor in multivariate analysis. The significance of place of surgery as well as other well-known prognostic factors underlines the importance of an experienced multidisciplinary treatment team if best results are to be obtained for the patient.


Larynx cancer Radiotherapy Surgery Prognostic factors Survival 


  1. 1.
  2. 2.
    Dosemeci M, Gokmen I, Unsal M, Hayes RB, Blair A (1997) Tobacco, alcohol use, and risks of laryngeal and lung cancer by subsite and histologic type in Turkey. Cancer Causes Control 8:729–737PubMedCrossRefGoogle Scholar
  3. 3.
    Dosemeci M, Hayes RB, Vetter R, Hoover RN, Tucker M, Engin K, Unsal M, Blair A (1993) Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control 4:313–321PubMedCrossRefGoogle Scholar
  4. 4.
    Shah JP, Cendon RA, Farr HW, Strong EW (1976) Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and the neck. Am J Surg 132:504–505PubMedCrossRefGoogle Scholar
  5. 5.
    Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, Morrison WH, Weber RS, Garden AS, Frankenthaler RA, Oswald MJ, Brown BW (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26:3–11PubMedGoogle Scholar
  6. 6.
    Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, McCaffrey TV, Olsen KD (1998) Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys 40(3):529–534PubMedGoogle Scholar
  7. 7.
    Nguyen- Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffınet DR, Fu KK (2001) Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the university of California, San Francisco (UCSF) and Stanford university hospital (SUH) experience. Int J Radiat Oncol Biol Phys 50(5):1172–1180PubMedGoogle Scholar
  8. 8.
    Looser KG, Shah JP, Strong EW (1978) The significance of positive margins in marginally resected epidermoid carcinoma. Head Neck Surg 1:107–111PubMedCrossRefGoogle Scholar
  9. 9.
    Rudoltz MS, Benammar A, Mohiuddin M (1995) Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy? Int J Radiat Oncol Biol Phys 31(3):503–508PubMedGoogle Scholar
  10. 10.
    Johnson JT, Barnes EL, Myers EN, Schramm VL, Borochovitz D, Siegler BA (1981) The extracapsular spread of tumors in cervical node metastases. Arch Otolaryngol 107:725–729PubMedGoogle Scholar
  11. 11.
    Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (1992) Manual for staging of cancer, 4th edn. J.B. Lippincott, Philadelphia, pp 27–44Google Scholar
  12. 12.
    Sobin LH, Fleming ID (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, Washington, pp 1803–1804Google Scholar
  13. 13.
    Bernier J, Domenge C, Eschwege F et al (2001) Chemo-radiotherapy as compared to radiotherapy alone, significantly increase disease-free and overall survival in head and neck cancer patients after surgery: results of EORTC phase III trial 22931. Int J Radiat Oncol Biol Phys 51(Suppl 1):1Google Scholar
  14. 14.
    Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, Geara FB, Klotch DW, Goepfert H, Peters LJ (2001) Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51(3):571–578PubMedGoogle Scholar
  15. 15.
    Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88–91PubMedCrossRefGoogle Scholar
  16. 16.
    Fowler JF, Lindstrom MJ (1992) Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23:457–467PubMedGoogle Scholar
  17. 17.
    Milecki P, Kruk-Zagajewska A, Stryczynska G (2002) Timing and duration of postoperative radiotherapy in patients with laryngeal cancer. Otolaryngol Pol 56(3):307–311PubMedGoogle Scholar
  18. 18.
    Muriel VP, Tejada MRG, Castillo JDL (2001) Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas. Radiother Oncol 60:137–145PubMedCrossRefGoogle Scholar
  19. 19.
    Vergeer MR, Doornaert P, Leemans CR, Buter J, Slotman BJ, Langendijk JA (2006) Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 79(1):39–44PubMedCrossRefGoogle Scholar
  20. 20.
    Nguyen TD, Malissard L, Theobald S, Eschwege F, Panis X, Bachaud JM, Rambert P, Chaplain G, Quint R (1996) Advanced carcinoma of the larynx: results of surgery and radiotherapy without induction chemotherapy (1980–1985): a multivariate analysis. Int J Radiat Oncol Biol Phys 36(5):1013–1018PubMedGoogle Scholar
  21. 21.
    Gallo A, Manciocco V, Simonelli M, Pagliuca G, D’Arcangelo E, de Vincentiis M (2005) Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg 131(7):620–625PubMedCrossRefGoogle Scholar
  22. 22.
    Weber R, Marvel J, Smith P, Hankins P, Wolf p, Goepfert H (1993) Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus. Otolaryngol Head Neck Surg 108:11–17PubMedGoogle Scholar
  23. 23.
    Thaler ER, Montone K, Tucker J, Weinstein GS (1997) Delphian lymph node in laryngeal carcinoma: a whole organ study. Laryngoscope 107:332–334PubMedCrossRefGoogle Scholar
  24. 24.
    Sparano A, Chernock R, Laccourreye O, Weinstein G, Feldman M (2005) Predictors of thyroid gland ınvasion in glottic squamous cell carcinoma. Laryngoscope 115:1247–1250PubMedCrossRefGoogle Scholar
  25. 25.
    Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB (1993) Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71(2):452–456PubMedCrossRefGoogle Scholar
  26. 26.
    Matsuo JMS, Patel SG, Singh B, Wong RJ, Boyle JO, Kraus DH, Shaha A, Zelefsky MJ, Pfister DG, Shah JP (2003) Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 238(3):412–421PubMedGoogle Scholar
  27. 27.
    Alvi A, Johnson JT (1997) Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck 19(6):500–505PubMedCrossRefGoogle Scholar
  28. 28.
    Rahima B, Shingaki S, Nagata M, Saito C (2004) Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(4):423–431PubMedCrossRefGoogle Scholar
  29. 29.
    Moe K, Wolf GT, Fisher SG, Hong WK (1996) Regional metastases in patients with advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 122:644–648PubMedGoogle Scholar
  30. 30.
    Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative Irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952PubMedCrossRefGoogle Scholar
  31. 31.
    Laramore GE, Scott CB, al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R, Jacobs JR, Schuller DE, Gahbauer RA, Schwade JG (1992) Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23(4):705–713PubMedGoogle Scholar
  32. 32.
    Cooper JS, Pajak TF, Forastiere AA, Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KSC, Schultz KJ, Lee N, Fu KK; for the Radiation Therapy Oncology Group 9501/Intergroup (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944Google Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Fadime Can Akman
    • 1
  • Nihal Dag
    • 1
  • Ozlem Uruk Ataman
    • 1
  • Cenk Ecevit
    • 2
  • Ahmet Omer Ikiz
    • 2
  • Isin Arslan
    • 1
  • Sulen Sarıoglu
    • 3
  • Emel Ada
    • 4
  • Munir Kinay
    • 1
  • Dokuz Eylül Head and Neck Tumour Group (DEHNTG)
  1. 1.Department of Radiation Oncology, Medical SchoolDokuz Eylül UniversityInciralti, IzmirTurkey
  2. 2.Department of Head and Neck Surgery, Medical SchoolDokuz Eylül UniversityInciralti, IzmirTurkey
  3. 3.Department of Pathology, Medical SchoolDokuz Eylül UniversityInciralti, IzmirTurkey
  4. 4.Department of Radiology, Medical SchoolDokuz Eylül UniversityInciralti, IzmirTurkey

Personalised recommendations